Singapore, June 22 -- Researchers at the University of Otago, New Zealand are investigating a blood-based prostate cancer detection approach using DNA methylation biomarkers. DNA methylation, a biological process that influences gene activity, has emerged as a promising area of cancer research, with scientists exploring how specific methylation patterns can serve as indicators of disease presence and progression.

The goal is to develop a more precise diagnostic tool that could complement or potentially improve upon existing screening methods.

The research also reflects the growing role of Indian-origin scientists in advancing global healthcare innovation. Cancer genomics researcher Aniruddha Chatterjee from the University of Otago is pa...